KNOLL PHARMA
- Sun Pharma eyes $300m acquisition in USThe company has a war chest of $700 million, for a “meaningful and opportunist’’ acquisition to continue with its strategy of organic growt...
- A question of chemistryPharma-Chemical onvergence model is distinctly on hold, the world over.
- Load More